Stéphane Dalle Selected Research

Brain Neoplasms (Brain Tumor)

1/2019

Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphane Dalle Research Topics

Disease

73	Melanoma (Melanoma, Malignant) 03/2024 - 02/2006
36	Neoplasms (Cancer) 12/2023 - 02/2006
13	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2016
11	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2002
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2023 - 03/2014
4	Obesity 01/2022 - 10/2014
4	Insulin Resistance 10/2019 - 02/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 02/2007
4	Lymphoma (Lymphomas) 01/2016 - 01/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2023 - 01/2015
3	Hyperglycemia 01/2023 - 01/2018
3	Mycosis Fungoides 01/2023 - 01/2008
3	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2004
3	Lymphatic Metastasis 11/2020 - 03/2016
2	Cardiotoxicity 12/2023 - 01/2022
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2023 - 01/2015
2	Panniculitis 01/2023 - 04/2013
2	Inflammation (Inflammations) 08/2022 - 01/2022
2	Diabetes Mellitus 12/2019 - 04/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 04/2019
2	Pure Red-Cell Aplasia 01/2019 - 01/2019
1	Pain (Aches) 02/2024
1	Hepatitis 06/2023
1	Drug-Related Side Effects and Adverse Reactions 05/2023
1	Amyloid Plaque 01/2023
1	Lipodystrophy 01/2023
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2023
1	type 1 Autoimmune polyendocrinopathy syndrome 01/2023

Drug/Important Bio-Agent (IBA)

18	pembrolizumabIBA 02/2024 - 02/2017
16	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2016
14	NivolumabIBA 10/2023 - 11/2017
13	IpilimumabIBA 10/2023 - 09/2012
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023 - 01/2017
6	B7-H1 AntigenIBA 01/2023 - 11/2019
6	Rituximab (Mabthera)FDA Link 01/2018 - 02/2007
5	AntibodiesIBA 12/2023 - 01/2014
5	CytokinesIBA 01/2023 - 03/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2008
5	Insulin (Novolin)FDA Link 01/2021 - 07/2006
5	VemurafenibIBA 05/2017 - 10/2011
4	Zinc Finger E-box-Binding Homeobox 1IBA 03/2024 - 10/2016
4	Peptides (Polypeptides)IBA 01/2023 - 02/2002
4	Monoclonal AntibodiesIBA 01/2022 - 05/2009
3	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2022
3	Programmed Cell Death 1 ReceptorIBA 11/2023 - 10/2020
3	relatlimabIBA 04/2023 - 01/2022
3	mogamulizumabIBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 03/2011
3	glucagon (19-29)IBA 10/2014 - 02/2002
2	SphingolipidsIBA 12/2023 - 01/2019
2	EnzymesIBA 12/2023 - 01/2020
2	LigandsIBA 01/2023 - 05/2018
2	AutoantibodiesIBA 01/2023 - 04/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	InterferonsIBA 01/2022 - 01/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2008
2	CateninsIBA 01/2022 - 01/2022
2	Chemokine ReceptorsIBA 08/2016 - 03/2016
2	Glucagon-Like Peptide-1 ReceptorIBA 05/2016 - 01/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 01/2006
2	Glucagon (Glukagon)FDA Link 10/2014 - 02/2005
2	Bexarotene (LGD1069)FDA Link 06/2014 - 01/2008
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2014 - 02/2013
2	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2014 - 02/2013
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2012 - 07/2008
1	Phosphotransferases (Kinase)IBA 02/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2024
1	Cadherins (E-Cadherin)IBA 12/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 12/2023
1	Small Cytoplasmic RNAIBA 12/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023
1	cemiplimabIBA 10/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023
1	Brentuximab VedotinIBA 07/2023
1	Prednisolone (Predate)FDA LinkGeneric 07/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023
1	Alkaline PhosphataseIBA 06/2023
1	Alanine Transaminase (SGPT)IBA 06/2023
1	C-Reactive ProteinIBA 01/2023
1	PolyphenolsIBA 01/2023
1	VenomsIBA 01/2023
1	Perilipin-1IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	AlkaloidsIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ProteomeIBA 01/2023

Therapy/Procedure

38	Therapeutics 03/2024 - 02/2006
13	Immunotherapy 01/2024 - 01/2016
4	Drug Therapy (Chemotherapy) 01/2023 - 03/2009
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2019
3	Radiotherapy 01/2019 - 01/2004
2	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 05/2014
1	Homologous Transplantation 10/2023
1	Precision Medicine 01/2023
1	Glycemic Control 01/2023